Short Term Comparative Assessment of MTA and Biodentine in Complete Pulpotomy for Symptomatic Irreversible Pulpitis
Short Term Outcome of Complete Pulpotomy Using MTA vs Biodentine in Symptomatic Irreversible Pulpitis - A Randomized Controlled Trial
1 other identifier
interventional
60
1 country
2
Brief Summary
All Patients coming to the Operative Dentistry Department (DIDC-DUHS) with complain of pain in posterior teeth will be invited to participate. The treatment will be done by one dentist. Patient's medical and dental history will be recorded, and tooth will be checked for swelling, sensitivity, cavity type, and loosening of tooth. Special tests like the cold test, electric pulp test, and an X-ray will help assess the tooth's condition. Patient will also be asked to rate pain from 1-10. Before starting the treatment, the procedure will be explained to patient in detail, and written consent will be taken. The treatment will be done in two visits by one dentist. Patient will be given an injection to make tooth pain-free so that patient does not feel any discomfort during the treatment and the area will be kept clean using a rubber sheet. The dentist will remove the hole in tooth and remove the infected soft part of tooth and stop the bleeding. Then one of the two materials will be placed inside the tooth. A temporary filling will be placed first, and patient will come the next day for the final filling. An X-ray will be taken to check the result. If patient feel pain, may take ibuprofen (400 mg) as needed, and if the pain continues, please contact the dentist. Patient will be called for follow-ups after 1 day, 1 week, 1 month, and 3 months to make sure the tooth is healing properly.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2024
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 2, 2024
CompletedFirst Submitted
Initial submission to the registry
November 28, 2025
CompletedFirst Posted
Study publicly available on registry
March 19, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2026
ExpectedMarch 19, 2026
October 1, 2025
1.5 years
November 28, 2025
March 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Short term outcome of complete pulpotomy using MTA vs Biodentine in Symptomatic Irreversible Pulpitis- A Randomized Controlled Trial
Clinical outcome measure through Electric pulp testing (EPT) and radiographic outcome measure through Periapical index (PAI)
3 months
Study Arms (2)
MTA
EXPERIMENTALPulpotomy material MTA
Biodentine
EXPERIMENTALPulpotomy material Biodentine
Interventions
Eligibility Criteria
You may qualify if:
- Teeth of generally healthy patients having following criteria will be included:
- Age between 18-40 years of both males and females
- Carious exposed maxillary and mandibular molars teeth
- Moderate to severe pain (VAS 4-10)
- Diagnosed with Symptomatic irreversible pulpitis on cold test and Electric pulp test (EPT)
- Periapical index of 1
- Hemostasis is achieved within 10 mins after full pulpotomy
You may not qualify if:
- Teeth of generally healthy patients having following criteria will be excluded:
- Any traumatic injury
- Non-restorable carious lesion
- Immature or Open apices of roots
- Internal or external Resorption
- Calcified canals
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Dr Khadija Zubair
Karachi, Sindh, Pakistan
Dr Khadija Zubair
Karachi, Sindh, Pakistan
Study Officials
- PRINCIPAL INVESTIGATOR
Dr Khadija Zubair, Postgraduate Trainee- FCPS
Dow University of Health Sciences
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Postgraduate Trainee FCPS
Study Record Dates
First Submitted
November 28, 2025
First Posted
March 19, 2026
Study Start
November 2, 2024
Primary Completion
April 30, 2026
Study Completion (Estimated)
July 31, 2026
Last Updated
March 19, 2026
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will not share
IPD will not be shared outside the study team to ensure patient confidentiality and privacy. Data will be used only for the purposes of this study and will remain restricted to the research team